Latest Jules Stein Stories
ACT Announces First Patients Undergo Embryonic Stem Cell Transplantation Treatment for Stargardt's Disease and Macular Degeneration at UCLA's Jules Stein Eye Institute
MARLBOROUGH, Mass., July 14, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc.
ACT Announces UCLA Institutional Review Board (IRB) Approval of its Phase 1/2 Clinical Trials using hESC-Derived RPE Cells for the Treatment of Macular Degeneration
MARLBOROUGH, Mass., April 28, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc.
Word of the Day
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.